{"id":"tp-57896","type":"article-newspaper","title":"Analysts Highlight Obesity Drugs and Sales Growth in Pharma Picks","author":"Token Post","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/insights/57896","datePublished":"2026-11-15T20:08:26.000Z","dateModified":"2026-11-15T20:08:26.000Z","language":"en","abstract":"Lilly’s tirzepatide and retatrutide featured alongside Gilead’s 6.8% revenue growth and a 35% rise in Sanofi’s Dupixent sales.","section":"Insights & Views","references":[]}